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PURPOSE. Gene therapy of retinal ganglion cells (RGCs) has promise as a powerful therapeutic
for the rescue and regeneration of these cells after optic nerve damage. However, early after
damage, RGCs undergo atrophic changes, including gene silencing. It is not known if these
changes will deleteriously affect transduction and transgene expression, or if the therapeutic
protein can influence reactivation of the endogenous genome.
METHODS. Double-transgenic mice carrying a Rosa26-(LoxP)-tdTomato reporter, and a mutant
allele for the proapoptotic Bax gene were reared. The Bax mutant blocks apoptosis, but
RGCs still exhibit nuclear atrophy and gene silencing. At times ranging from 1 hour to 4
weeks after optic nerve crush (ONC), eyes received an intravitreal injection of AAV2 virus
carrying the Cre recombinase. Successful transduction was monitored by expression of the
tdTomato reporter. Immunostaining was used to localize tdTomato expression in select cell
types.
RESULTS. Successful transduction of RGCs was achieved at all time points after ONC using
AAV2 expressing Cre from the phosphoglycerate kinase (Pgk) promoter, but not the CMV
promoter. ONC promoted an increase in the transduction of cell types in the inner nuclear
layer, including Mu¨ller cells and rod bipolar neurons. There was minimal evidence of
transduction of amacrine cells and astrocytes in the inner retina or optic nerve.
CONCLUSIONS. Damaged RGCs can be transduced and at least some endogenous genes can be
subsequently activated. Optic nerve damage may change retinal architecture to allow greater
penetration of an AAV2 virus to transduce several additional cell types in the inner nuclear
layer.
Keywords: gene therapy, retinal ganglion cells, optic nerve damage
Adeno-associated virus, serotype 2 (AAV2) has become theprincipal vector for transducing retinal ganglion cells
(RGCs) with recombinant genes. Native AAV2 efficiently infects
RGCs, transducing upward of 85% of the population of these
cells1,2 after intravitreal injection of adult rodent eyes. Nearly all
of the investigations on AAV2-mediated gene transfer into RGCs
have been done on na¨ıve tissues (i.e., before optic nerve
damage), in an effort to validate gene therapeutic treatment of
optic neuropathies, such as glaucoma. It is likely, however, that
future therapies will be conducted on RGCs in a tissue that has
already experienced some level of damage. This may be
problematic to achieving a successful outcome. In response
to damage, RGCs undergo changes in chromatin structure that
precipitate the condensation of euchromatin to heterochroma-
tin, and the early and rapid silencing of normal gene
expression.3–6 These changes are largely controlled by an
increase in histone deacetylase (HDAC) activity, including the
translocation of HDAC3 from the cytoplasm to the nucleus
shortly after damage.3 It is not clear if these changes would
present a hostile or repressive transcriptional environment to a
newly introduced transgene. Recombinant AAVs introduce
their genome as single-stranded molecules containing inverted
terminal repeats. In the nucleus, AAV genomes are converted to
double-stranded molecules, which concatenate into circular
episomes,7 which can become chromatinized.8 Thus, the AAV
cargo DNA may be subject to the same rules of heterochroma-
tin formation that govern the endogenous genome. Similarly,
even if the exogenous transgene was expressed, the endoge-
nous genome may be in a state that is refractory to the actions
of therapeutic transgene products such as transcription factors.
Because these nuclear changes occur early in the apoptotic
program of RGCs, it is possible that this could present a
significant barrier to the successful outcome of any neuropro-
tective strategy.
Even before consideration of whether or not a transgene
could be expressed, the question of how well damaged RGCs
can be transduced has not been addressed. AAV2 uses heparin
sulfate as the primary receptor for attachment and internaliza-
tion into cells,9 but it also binds to the 150-kDa glycoprotein
AAV-receptor,10,11 various growth factor receptors,12,13 aVb5
integrin,14 and the 37/67 kDa laminin receptor.15 It is well-
established that damaging insults that result in RGC death are
correlated with widespread proteolytic changes in the retinal
extracellular matrix,16–18 but how this extends to the biochem-
istry of the RGC plasma membrane is not known. Damaged
RGC somas undergo dramatic morphological changes, typified
by retraction of the dendritic arbor19–23 with evidence of
nuclear and soma shrinkage.24,25 This spectrum of changes
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makes it uncertain if the necessary cell surface cues required
for viral interaction are retained in damaged cells.
To address these issues, we examined the ability of gene
therapy using AAV2 to deliver the Cre recombinase to RGCs
after optic nerve damage. Rosa26-(LoxP)-tdTomato mice were
used as the reporter strain to document successful activation of
an endogenous gene in response to the activity of the
exogenous Cre transgene. To help preserve a normal compli-
ment of RGCs, and to mimic a neuroprotective intervention,
we crossed these mice to Baxþ/ mice (also on the C57BL/6J
background) to generate animals carrying both the reporter
and one or two mutant Bax alleles. Previous studies have
shown that all of the early changes in chromatin remodeling
and gene silencing are duplicated in Bax-deficient mice,25 even
though the RGCs are highly resistant to completion of the
apoptotic program.26 Activation of the tdTomato reporter gene
in damaged RGCs of these mice would simultaneously verify
that AAV2 can interact with and transduce these cells; that the
transgene (Cre recombinase) can be expressed; and that the
transgene product can interact with the endogenous RGC
genome to facilitate the expression of a normally silenced gene
(Rosa26-(LoxP)-tdTomato). Here we show that all three
objectives could be met, even in mice transduced with AAV2-
Cre up to 1 month after acute optic nerve injury. In addition to
successful RGC transduction, optic nerve injury dramatically
increased the transduction efficiency of multiple other cell
types, primarily in the retinal inner nuclear layer. This increase
in promiscuity of retinal cell transduction may affect future
therapeutic strategies and/or outcomes using gene therapy.
MATERIALS AND METHODS
Animals
Adult mice (4–6 months of age) were used for these studies and
were handled in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research. All
experimental protocols were approved by the Animal Care and
Use Committee and the Office of Biosafety at the University of
Wisconsin-Madison. Mice were housed in microisolator cages
and kept on a 12-hour light/dark cycle and maintained on a 4%
fat diet (8604 M/R, Harland Tekland, Madison, WI, USA). Rosa26-
(LoxP)-tdTomato mice (B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze,
Stock 007909; Jackson Laboratories, Bar Harbor, ME, USA) were
crossed with C57BL/6J animals heterozygous for a targeted
deletion of the Bax gene (gift from Stanley Korsmeyer and made
congenic onto the C57BL/6J genetic background) to generate
double-transgenic Rosa26-(LoxP)-tdTomato/Bax–deficient mice.
Experiments were conducted on mice that were either
homozygous (Bax/) or heterozygous (Baxþ/) for the mutant
Bax allele. Previous studies have documented that RGCs in
Bax/ mice exhibit complete resistance to completion of the
apoptotic program after optic nerve crush (ONC),26–28 whereas
the Baxþ/ mice congenic on the C57BL/6J background exhibit
RGC loss beginning at approximately 10 weeks after ONC
(Donahue R and Nickells R, unpublished observations, 2017).
This onset of cell death in Baxþ/ mice is significantly retarded
relative to wild-type animals, which first begin to lose cells at 5 to
7 days after crush, progressing to maximal cell loss by 3
weeks.29–31
ONC and Viral Injections
Mice were subjected to ONC surgery of the left eye as
described previously30,31 and allowed to recover for different
periods of time ranging from 1 hour to 4 weeks. The mice then
received a single intravitreal injection of either AAV2-CMV-Cre/
GFP (Vector Biolabs, Philadelphia, PA, USA) or AAV2-Pgk-Cre
(University of North Carolina Vector CORE, Chapel Hill, NC,
USA) (1 lL containing ~2–53109 viral genomes). Briefly, mice
were anesthetized with ketamine/xylazine and the experimen-
tal eye numbed with a drop of proparacaine. The globe was
first punctured using the bevel of a 30-G needle, and
intravitreal injections were made using a Nanofil syringe and
35-G beveled needle (World Precision Instruments, Sarasota,
FL, USA), which was inserted through the puncture site. Virus
was injected slowly over 60 seconds. The needle was then
withdrawn over another 60 seconds, and the puncture site was
covered with triple antibiotic ointment. Mice were inspected
daily for ocular infections or lens opacities that may have
resulted from needle damage during injection, but none of the
mice used in this study exhibited any adverse effects. Four
weeks after injection, the mice were euthanized and the
retinas processed for analysis. All times given in reference to
experimental results refer to the time between ONC surgery
and intravitreal injection of virus, and do not reflect the
additional 4 weeks of incubation necessary to allow for second-
strand synthesis and expression of AAV2-delivered DNA
content.
Image Analysis and Immunostaining
All procedures, where possible, were conducted in low-level
lighting so as not to bleach the fluorescent signal of the
tdTomato reporter protein. After euthanasia, whole globes
were enucleated and emersion fixed in 4% paraformaldehyde
in PBS (50 mM phosphate buffer, pH 7.4, 150 mM NaCl) at
228C between 30 and 60 minutes. Globes were then dissected
to remove the anterior chamber and lens, and the resulting
eyecup was incubated in 0.4% paraformaldehyde in PBS,
overnight at 48C. Eyecups were then equilibrated in 30%
sucrose in PBS and embedded in optimum cutting temperature
compound (Tissue-Tek; Sakura Finetek USA, Inc., Torrance, CA,
USA). Sections were cut at 10 lm and affixed to Superfrost Plus
microscope slides (ThermoFisher Scientific, Waltham, MA,
USA). Sections were chosen for analysis that contained
substantial portions of the optic nerve. Sections were blocked
in PBS containing 2% BSA and 0.1% Triton X-100 overnight at
48C in humidified chambers. Primary antibodies were then
applied in the same buffer for 48 hours at 48C. The primary
antibodies included anti-BRN3A (1:100 dilution, MAB1585;
EMD Millipore, Billerica, MA, USA), anti-SOX9 (1:500 dilution,
AB5535; EMD Millipore), anti-PKCa (1:100 dilution, sc-208;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Calretinin
(1:50 dilution, AF5065; R&D Systems, Minneapolis, MN, USA),
and anti-heparin sulfate (1:100 dilution, MAB2040; EMD
Millipore). After incubation, sections were washed thoroughly
in PBS and then incubated in the appropriate secondary
antibody conjugated to either Alexa-488 or FITC. All secondary
antibodies were purchased from Jackson ImmunoResearch
(West Grove, PA, USA) and used at a dilution of 1:1000 in PBS,
2% BSA, and 0.1% Triton X-100 buffer. Secondary antibodies
were applied for 2 hours at 228C, or overnight at 48C, followed
by washing in PBS. Sections were then incubated in water
containing 300 ng/mL 40,6-diamindine-20-phenylindole dihy-
drochloride (DAPI; ThermoFisher Scientific) for 5 minutes at
228C, followed by washing and mounting with Immu-Mount
(ThermoFisher Scientific). Sections were imaged and digitally
photographed on a Nikon Eclipse Ti inverted confocal
microscope (Nikon, Melville, NY, USA) configured with an
Andor Laser Combiner (Andor, Belfast, Northern Ireland).
Emission band pass filters used for imaging were tdTomato
(589–625 nm) and Alexa-488/FITC (510–540 nm). Individual
fields were imaged as Nyquist Z-stacks of 10 to 15 steps (0.22
lm each) and then used to construct three-dimensional images
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using IMARIS 7.7 image analysis software (Bitplane, Concord,
MA, USA).
Transmission Electron Microscopy
Smaller regions of eyecups processed as described above,
which included the retina, were emersion fixed in Karnovsky’s
fixative (2.5% glutaraldehyde and 2% paraformaldehyde in 200
mM Cacodylate buffer, pH 7.4) overnight at 48C. The tissue was
then post-fixed in 1% osmium tetroxide in phosphate buffer,
dehydrated, and embedded in Epon epoxy. Sections (60–90
nm) were cut and stained with 50% ethanoic uranyl acetate
and Reynold’s lead citrate and viewed using a Phillips CM120
transmission electron microscope (FEI Company, Hillsboro,
OR, USA).
Counting Protocol and Statistical Analysis
The number of tdTomato-expressing cells in retinal sections
was quantified as follows. Five sections each of three retinas
were counted from virus-injected eyes that did not receive
ONC or virus-injected eyes, 2 weeks after ONC. All counting
experiments were conducted on Baxþ/ mice. Counts were
obtained across the entire retinal section and reported as the
number of positive cells along a 100-lm distance. From the
images, it was evident that positive cells in the inner nuclear
layer resided generally in the outermost and innermost
portions of this layer. Therefore, the inner nuclear layer (INL)
was divided into two leaflets, and counts were acquired in
each separately. Counts were then reported as the mean and
SD for the ganglion cell layer (GCL) and the two halves of the
INL. These means were compared between undamaged and
optic nerve–damaged retinas using a 2-tailed Student’s t-test
with a significance level of P ¼ 0.05.
RESULTS
Comparison of Cytomegalovirus (CMV) and
Phosphoglycerate Kinase (Pgk) Promoter Activity
to Drive Cre Expression in Damaged RGCs
In initial experiments, Bax-deficient mice were subjected to
ONC and injected with virus within 1 hour to 2 days after
damage. This time window was chosen because it was
expected to be before the completion of heterochromatin
formation in damaged RGCs.3,5,25 Figure 1 shows lobes from
representative retinas from this study. Retinas in eyes exposed
to the AAV2-CMV-Cre virus exhibited few labeled cells, which
were mostly clustered in the periphery. Previously, in
injections of na¨ıve eyes of Rosa26-(LoxP)-tdTomato mice, we
have achieved widespread transduction of cells in the GCL
using this virus.5 Mice injected with the AAV2-Pgk-Cre virus,
however, exhibited dramatic transduction and subsequent
expression of the tdTomato reporter gene in the GCL at all time
points. Both Bax/ and Baxþ/ mice exhibited similar
widespread transduction. All future experiments were con-
ducted using AAV2-Pgk-Cre.
Transduction of Multiple Retinal Cell Types by
AAV2-Pgk-Cre After ONC Injury
Figure 2 shows more detailed microscopic examination of the
transduction of retinas in Baxþ/ mice injected with AAV2-Pgk-
Cre 2 weeks after optic nerve injury. Confocal imaging of the
GCL showed extensive cell labeling (en fosse image, Fig. 2A),
and also revealed that a proportion of tdTomato-expressing
cells were present in the outer retina, including cells with long
processes extending toward the outer limiting membrane. A
common feature of these cells was that they were grouped into
distinct clusters (Fig. 2B), whereas cells in the GCL were
distributed more uniformly. Sections of retina showed exten-
sive tdTomato-expressing cells in the GCL and INL, including
cells that extended long processes to the nerve fiber layer and
outer limiting membrane, suggestive of Mu¨ller cells. Addition-
ally, there was strong labeling in the proximal optic nerve up to
the point of injury (Figs. 2C, 2D). Higher-magnification imaging
of the optic nerve revealed that the bulk of the reporter
protein was present in presumptive RGC axons, and not in
astrocytes, which were positive for SOX9 immunoreactivity
(Fig. 2E).
A comparison of retinas from undamaged eyes and retinas
from eyes after ONC showed that more cells in the INL
appeared to be expressing the tdTomato reporter in retinas
after ONC surgery (Figs. 3A, 3B). Quantification of the number
of cells per 100 lm of sectioned retina showed that there was
no difference in labeled cells between the two conditions in
the GCL, but there were significant increases in the numbers of
cells in both the innermost portion (2.1-fold increase) and
outermost portion (3.4-fold increase) of the INL (Fig. 3C).
We then examined if optic nerve damage affected either the
structural integrity of the inner limiting membrane or increased
the overall pattern of expression of heparin sulfate throughout
the retina, two of the most likely mechanisms that would lead
to increased transduction of cells in the inner retina.
Transmission electron microscopy of sections of the na¨ıve
mouse retina, or retinas taken from the contralateral control
eye of experimental animals (n ¼ 4) all showed a well-
structured inner limiting membrane (ILM) with a flocculent
material lining the vitreous face of the membrane (Supple-
mentary Figure S1). Retinas from eyes 5 days after optic nerve
damage (n¼ 4) also exhibited an ILM, but also showed regions
where the integrity of the membrane transitioned to a
disorganized fuzzy material. This was consistent for eyes from
both wild-type and Bax-deficient mice. At 14 days after optic
nerve damage, some retinas exhibited no evidence of an ILM in
regions. These results were consistent with regional break-
down of the ILM leading to the clusters of transduced cells in
the inner retina shown in Figure 2B. Conversely, sections
stained for heparin sulfate showed no distinct difference in the
pattern of immunolabeling for this moiety between contralat-
eral control and damaged retinas (Supplementary Figs. S1D,
S1E). The damaged retinas were processed between 6 and 8
weeks after optic nerve damage, however, and may not reflect
a more immediate response in changes in the proteoglycan
distribution after damage.
Discovery of Cell Types Transduced by
AAV2-Pgk-Cre
The presence of the tdTomato reporter protein in axons of the
optic nerves of eyes provides compelling evidence that
damaged RGCs were successfully transduced by the virus and
yielded subsequent transgene expression. To validate this,
however, sections of Bax/ eyes, injected with virus 4 weeks
after optic nerve damage, were counterstained with an
antibody against BRN3A to identify RGC somas in the GCL.
Figure 4 shows colocalization of tdTomato with a majority of
BRN3A-positive cells. There were also patchy areas of reporter
gene expression that were not associated with a nucleus
located at the interface between the GCL and the nerve fiber
layer. These may have been Mu¨ller end feet (see below). In
some regions of these retinas, BRN3A labeling appeared to be
redistributed to the nuclear envelop or completely extruded
from the nucleus. These cells were also often positive for
tdTomato expression (Fig. 5). The proportion of cells with
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nuclear and extruded BRN3A labeling combined was 46.5% 6
15.5% of the nuclei in the GCL of Baxþ/ mice, which
compares to the 44.8% 6 9.1% of cells reported in an earlier
study.32 This suggests that cells exhibiting extruded BRN3A are
RGCs and that redistribution of BRN3A may be a unique
phenomenon warranting further investigation. Quantitatively,
we measured the proportion of cells in the GCL that exhibited
either expression of one or both markers (BRN3A or
tdTomato). An average of 69.7% of these cells were positive
for both markers, whereas 19.8% and 10.5% were positive for
FIGURE 1. Retinal whole mounts showing tdTomato reporter gene expression after AAV2-Cre transduction. In all cases, the time stamp shows the
point post-ONC (pONC) when virus was injected into the vitreous of the eye. Expression of the tdTomato reporter was assessed 4 weeks after viral
injection. (A, B) Lobes of na¨ıve retinas after intravitreal injection of AAV2-CMV-Cre (A) or AAV2-Pgk-Cre (B). Both viruses provide extensive
transduction of cells in the GCL leading to robust tdTomato expression. (C) Lobe of a Bax/ retina transduced with AAV2-CMV-Cre 2 days after
ONC surgery. Sparse labeling of cells is detected in the retinal periphery. Transduction of retinas with the AAV2-Pgk-Cre virus, however, yields
dramatically widespread reporter gene expression. (D) A Bax/ retina transduced 1 hour after ONC. (E) A Baxþ/ retina transduced 6 hours after
ONC. (F) A Bax/ retina transduced 2 days after ONC. Similar levels of expression were also detected in retinas transduced at 2 and 4 weeks after
ONC in these mice. Scale bar: 200 lm.
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FIGURE 2. Multiple retinal cell types are transduced by AA2-Pgk-Cre. (A) En fosse confocal image of the GCL of a Baxþ/ mouse injected 2 weeks
pONC. A large number of cells are expressing the tdTomato reporter, suggesting efficient transduction of RGCs in this layer. (B) A 458 tilt of the Z-
stack of this image shows that clusters of transduced/expressing cells extend into the outer retina, with prominent cell bodies in the INL. Scale bar:
10 lm. (C) A section through a Baxþ/ mouse retina and optic nerve, transduced 2 weeks pONC. Note extensive labeling of the optic nerve. Scale
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either BRN3A or tdTomato alone, respectively (Fig. 6). Thus,
most transduced cells in the GCL were ganglion cells. It is
notable that in na¨ıve retinas, fewer than 2% of tdTomato-
expressing cells did not also express an RGC marker such as
BRN3A or bIII tubulin (data not shown). Cells that exclusively
expressed the tdTomato reporter may have represented RGCs
that were not BRN3A positive,32,33 or could have been cells
that had experienced damage-induced silencing of this gene.34
It is also possible that some of these tdTomato-positive cells
were not RGCs. Rare positive cells, for example, had the
appearance of astrocytes (Fig. 5), although these cells did not
colocalize with a marker for macroglia (see below).
The principal cell type showing increased tdTomato expres-
sion in the INL was expected to be Mu¨ller cells, based on
morphological criteria of positively labeled extensions to the
inner and outer limiting membranes, and ellipsoid-shaped nuclei
in the outermost region of the INL. To verify that these were
Mu¨ller cells, we counterstained sections with an antibody against
the transcription factor SOX9, which selectively stains the nuclei
of macroglia, including astrocytes,35 and Mu¨ller cells in the
retina.36 Figure 7 shows that many, but not all of the Mu¨ller cells
labeled with anti-SOX9 were also strongly positive for tdTomato
expression. Notably, SOX9 positive cells in the GCL, identified as
astrocytes, did not show tdTomato expression, similar to the
observations made in the optic nerve (Fig. 2E).
Mu¨ller cells accounted for many of the reporter-positive
nuclei present in the outermost region of the INL, but did not
identify a subpopulation of cells with more rounded nuclei,
which were also positive. These cells were in a region of the
INL known to be populated by the nuclei of rod bipolar cells.
To test if these cells were transduced, sections of retinas were
counterstained with an antibody against PKCa, which selec-
tively stains rod bipolar cells.37 Figure 8 shows that most rod
bipolar cells were also expressing tdTomato. Interestingly,
although the reporter protein was prevalent throughout the
cytoplasm of both RGCs and Mu¨ller cells, in the bipolar cells
fluorescent signal appeared to be restricted to the nuclei.
To evaluate the possibility that amacrine cells made up most
cells in the innermost half of the INL, we stained sections with
an antibody against Calretinin, which selectively stains AII
amacrine cells in the neural retina.38 There were few if any AII
amacrine cells that showed colocalization of both proteins (Fig.
9). AII amacrine cells that did appear to be expressing
tdTomato proved to be situated above a second tdTomato-
expressing cell when the Z-stack of images was rotated. Lack of
tdTomato expression was evident in AII amacrine cells both in
the INL, and displaced cells in the GCL (Fig. 9).
FIGURE 3. Damage to the optic nerve increases the transduction of
retinal cells by AAV2-Pgk-Cre. Sections of Baxþ/ mouse retinas
transduced with AAV2-Pgk-Cre. (A) A section from a control
(contralateral eye) that did not receive optic nerve injury. Some cells
in the INL and GCL are expressing the tdTomato reporter gene. The
bar: 500 lm. (D) A higher-magnification image of the retina. Multiple cell types appear to be expressing the reporter gene, some sending processes
to the outer limiting membrane (OLM). Scale bar: 50 lm. No labeling of photoreceptors, however, was evident. (E) Labeling in the optic nerve is
restricted to RGC axon fibers (arrowheads), while astrocytes (immunostained with SOX9, green) appear unlabeled. Scale bar: 5 lm. DAPI
counterstain in (C–E).
dotted line indicates the stratification of the INL into innermost and
outermost sections for cell counting. (B) A retina transduced 2 weeks
after optic nerve damage. A dramatic increase in the numbers of
tdTomato-expressing cells is evident in the INL. No labeling of
photoreceptors was evident. Scale bar: 50 lm. DAPI counterstain.
(C) Quantification of labeled cells in the different regions of retinas (n
¼ 3 retinas for each condition). Positive cells were counted along 100-
lm distances of retinal sections. The means 6 SDs are graphed
(minimum of 44 microscopic fields per condition counted). There was
no significant change in the numbers of GCL cells that were transduced
(t-test, P¼ 0.165). In the innermost region of the INL, there was a 2.1-
fold increase in the numbers of cells (*P < 0.001). In the outermost
region there was a 3.4-fold increase in the numbers of cells transduced
(**P < 0.0001).
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DISCUSSION
We tested the ability of AAV2 to introduce a gene of interest
into RGCs after optic nerve damage. This study was
precipitated by the need to understand the dynamics of
AAV2-mediated gene transduction in RGCs that were in the
early stages of the apoptotic pathway, because we predict that
this would be the condition of RGCs for future application of
FIGURE 4. tdTomato reporter expression in RGCs. Bax/ retinas, transduced 4 weeks pONC were counterstained with an antibody against the
RGC marker BRN3A (green). (A) Survey view of a retinal section showing the GCL, INL, and outer nuclear layer (ONL). Scale bar: 50 lm. (B–D)
BRN3A-positive cells (arrows) are also expressing the tdTomato reporter. Scale bar: 5 lm. DAPI counterstain in (B–D).
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gene therapy in diseases affecting the optic nerve, even
including cells that were ‘‘rescued’’ by a neuroprotective
treatment. Perhaps the greatest concern was that RGCs
undergo early atrophy of the nucleus and condensation of
the genome,3,4,25 even under conditions in which the
apoptotic pathway had been blocked. Thus, it was uncertain
if an exogenous transgene would even be expressed, or if so,
would the product be able to influence expression of silenced
endogenous genes. The results in this study indicate that not
only can damaged RGCs be transduced, but also that
expression of the therapeutic gene, and subsequently an
endogenous gene, can be achieved. It is important to note that,
by design, successful transduction is monitored by the
amplified signal from the expression of the Rosa26-(LoxP)-
tdTomato reporter gene. Thus, we cannot assess the quanti-
tative level of successful viral transgene expression, because
small and large amounts of Cre expression would result in the
same activation of the reporter gene, which is then indepen-
dently sustained (whereas Cre expression could be transient).
The amplification step, however, does dramatize the difference
in overall retinal transduction between uninjured and injured
retinas (see below). Additionally, it is important to note that the
Rosa26 locus is well-characterized for its ability to stay
transcriptionally active during transition periods when the
genome of a cell is being reset to a new transcriptome, such as
during development.39,40 These transitions involve nuclear
remodeling of heterochromatic and euchromatic regions,
similar to what we observe in apoptotic RGCs. Thus, the
Rosa26 locus may have an extended transcriptional potential
that is not representative of other endogenous genes.
Promoter Differences in Transduction of Damaged
RGCs
An important observation from these experiments is the
relatively poor success achieved with the CMV promoter. We
interpret this result as being indicative of poor expression from
the promoter in cells of the affected retina. It is well known
that the CMV promoter is only transiently expressed in
vivo,41,42 but this is unlikely to explain the low levels of
transduced cells in our experiments. The outcome measure of
FIGURE 5. BRN3A becomes redistributed in some RGCs after damage. (A–C) Detail of tdTomato-positive cells colocalized with BRN3A. Of the four
cells shown, three exhibit BRN3A localization that is in various stages of distribution between the nuclear and cytosolic compartments (asterisks).
The arrow marks a cell with typical nuclear BRN3A localization. (D–E) A tdTomato-positive cell that is negative for BRN3A labeling. The flattened
morphology is similar to the normal appearance of astrocytes. The BRN3A-positive cells exhibit both nuclear (arrow) or cytosolic (asterisks)
distribution of BRN3A. Scale bar: 8 lm.
FIGURE 6. Quantification of BRN3A and tdTomato-expressing cells in
the ganglion cell layer of optic nerve–damaged eyes. Data were
collected from both Baxþ/ and Bax/ mice (n ¼ 2 each) transduced
between 2 and 4 weeks after ONC. The number of cells expressing
BRN3A, tdTomato, or both, were scored and the percentage of each
category of cells from that total was plotted for each of 31 different
sections. An average of 69.7% of the cells were positive for both
markers, whereas 19.8% and 10.5% were positive for only BRN3A or
tdTomato, respectively.
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FIGURE 7. tdTomato reporter expression in Mu¨ller cells. Bax/ retinas, transduced 4 weeks pONC were counterstained with an antibody against
SOX9 to identify Mu¨ller cells. (A) Survey view of a retinal section showing the GCL, INL, and ONL. Scale bar: 50 lm. (B–D) Nuclei, principally in the
outermost region of the INL are positive for the SOX9 antigen. Many of them also express the tdTomato reporter (arrows), indicating transduction of
these cells with the AAV2-Pgk-Cre vector. Several tdTomato-expressing cells, also in this half of the INL, but with more rounded nuclei, are also
present, but do not express the SOX9 antigen. Scale bar: 5 lm. DAPI counterstain.
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our experiments was the activation of the Rosa26-(LoxP)-
tdTomato gene, and we would assume even transient
expression from the CMV promoter would have generated
sufficient Cre recombinase to cause activation, as is the case in
transduced na¨ıve retinas. Reduced expression from the CMV-
driven promoter may be a by-product of the increased HDAC
activity in RGCs, which has been shown in other cell types to
reduce the activity of this promoter.43 It is important to note
FIGURE 8. tdTomato reporter expression in rod bipolar cells. Bax/ retinas, transduced 4 weeks pONC were counterstained with an antibody
against PKCa. (A) Survey view of a retinal section showing the GCL, INL, and ONL. Scale bar: 50 lm. (B–D) Rounded nuclei in the outermost region
of the INL exhibit tdTomato reporter gene expression, which colocalizes with PKCa immunoreactivity (arrows). Scale bar: 5 lm. DAPI
counterstain.
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FIGURE 9. AII amacrine cells do not express the tdTomato reporter gene. Bax/ retinas, transduced 4 weeks pONC were counterstained with an
antibody against Calretinin. (A) Survey view of a retinal section showing the GCL, INL, and ONL. Scale bar: 50 lm. (B–D) Calretinin expressing AII
amacrine cells are present in the innermost layer of the INL and in the GCL. There was no apparent colocalization with any tdTomato-expressing
cells in either layer with the Calretinin stain. Some cells, which do show overlap of stain (arrowheads), were found to be distinct overlapping cells
in the section when the confocal Z-stack was rotated. Scale bar: 5 lm. DAPI counterstain.
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that our initial experiments using AAV2-CMV-Cre/GFP were
limited to evaluation of cells in the GCL. Sectioning of a few
na¨ıve retinas transduced with this virus did reveal a few cells in
similar locations of the INL were also transduced, but not to
the extent of the AAV2-Pgk-Cre virus (data not shown).
Therefore, the enhanced level of expression in the INL after
optic nerve damage also may be a function of promoter choice.
Others have shown that promoter choice improves expression
of AAV2-delivered transgenes in the retina.44 We selected the
Pgk promoter on the basis of phosphoglycerate kinase being
an enzyme involved in glycolysis, and therefore expected to be
essential to cell homeostasis under a variety of conditions,
including after damage. This promoter has been used to drive
transgene expression in RGCs for at least 7 months.45
Additionally, we predict that genes involved in the glycolytic
pathway to continue to be expressed in Bax-deficient RGCs,
because these cells remain viable for up to 18 months after
optic nerve damage in mice.26
Retinal Cell Types Transduced After Optic Nerve
Damage
In addition to RGCs, the AAV2-Pgk-Cre virus was able to
transduce (and activate tdTomato expression) in a variety of
other cell types. The level of transduction of these other cells
was significantly increased after optic nerve injury. It is already
well known that AAV2 can infect multiple different retinal cell
types. The apparent increased trophism for RGCs after
intravitreal injection is most likely a function of tissue-derived
barriers, such as the nerve fiber layer and the ILM, which have
been shown to impede viral access to other retinal cell types.46
Enzymatic digestion of the ILM is able to increase AAV2
penetration to the outer retina.46 Similarly, alterations in the
viral capsid,47,48 or mixing the virus with exosomes,49
dramatically improves retinal penetration of AAV2, allowing
for the transduction of a variety of other retinal cell types,
including photoreceptors and RPE.
We predict that damage to the optic nerve leads to tissue
modifications in the retina that increases permeability of the
AAV2-Pgk-Cre virus to access other retinal cell types. Others
have shown that retinal damage resulting from photoreceptor
degeneration can increase the penetration, and possibly
transduction efficiency, of several AAV serotypes.50 In addition,
enzymatic treatment of the ILM and vitreous results in similar
increased penetration of AAV serotypes.44,46 In a primate eye,
transduction of the inner cells of the retinal fovea is increased
in eyes that had experienced RGC loss due to cortical
infection.44 We predict that optic nerve damage produces a
similar breakdown of the ILM, which appears less well
organized, or absent, in retinas after crush surgery at the
ultrastructural level. In the case of acute optic nerve damage,
the remodeling of the ILM may not be uniform, and seems to
occur in select regions allowing for viral transduction of
patches or groupings of cells such as what we observed for the
Mu¨ller cells. At this point, however, we cannot rule out that
certain retinal cell types change their surface chemistry in
response to damage resulting in a more favorable binding
environment for the virus. Immunostaining for heparin sulfate,
the principal cell surface ligand for AAV2 binding, did not
provide conclusive evidence of a dramatic change in expres-
sion pattern in damaged retinas.
Transduced cells in the INL appeared to be positioned
generally in two distinct regions, the outermost edge and
the innermost edge. In the outermost edge, most of these
cells are likely a combination of Mu¨ller cell somas and rod
bipolar cells. Nuclear staining, which is prominent with the
tdTomato reporter, shows that Mu¨ller cells have elongated
nuclei, whereas the nuclei of bipolar cells are more
rounded. Several rounded tdTomato-positive nuclei in this
region, however, are not colabeled with the antibody to
PKCa, and may represent cone bipolar cells. These results
are in agreement with other studies in which AAV2
penetration into the retina was increased. Wassmer and
colleagues,49 for example, showed AAV2-mediated transduc-
tion of multiple CaBP5-expressing cells, which is indicative
of both rod and cone bipolars. The cell type(s) that express
the tdTomato reporter in the innermost region of the INL
are, as yet, not identified. Although this is the region where
amacrine cells are anatomically located, neither Calretinin-
positive amacrine cells (this study) or ChAT-positive
amacrine cells49 appear to be transduced. This is also
evident in the displaced amacrine cells in the GCL. Given
the position of these unknown transduced cells, however, it
is still likely that they are one of the 40 different subtypes of
amacrine cells in the mammalian retina.51 Last, astrocytes
identified by SOX9 staining did not appear to be transduced
in either the GCL or the optic nerve, although rare
tdTomato-positive cells with astrocyte-like morphology were
detected in the GCL.
Practical Considerations for Using AAV2-Mediated
Gene Therapy in Retinas After Optic Nerve Damage
Gene therapy holds promise as a powerful way to treat RGCs
and prevent their death and/or stimulate their regeneration.
This study fills a gap in our knowledge base by showing that
partially damaged RGCs can be successfully transduced,
express a transgene, and that the endogenous, silenced,
genome can be activated to some degree. Although successful
transduction of RGCs is encouraging, the increase in transduc-
tion of multiple other retinal cell types has both potential
positive and potential negative consequences. Increased
transduction of cells such as Mu¨ller cells may provide a
broader platform for the synthesis and secretion of therapeutic
molecules such as trophic factors.52 Alternatively, molecules
specifically targeting RGCs may subsequently damage, alter, or
kill other retinal cell types. Under these circumstances,
promoter choice will be a critical consideration.
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